Radiation Oncology

Christopher J. Schultz, MD Professor of Radiation Oncology Medical Director, Radiation Oncology Froedtert & Medical College Clinical Cancer Center Department of Radiation Oncology 8701 Watertown Plank Road Milwaukee, WI 53226 (414) 805-4480

Curriculum Vitae

Patient Care Emphases

• Head and Neck Cancer
• Hodgkin's Disease
• Low Dose Rate Irradiation
• Gamma Knife Stereotactic Radiosurgery
• Lymphoma
• Brain Tumors

Clinical Practice Locations

• Froedtert & Medical College Clinical Cancer Center: (414) 805-4400
• Community Memorial Hospital: (262) 257-5151

Education

• Doctor of Medicine, Medical College of Wisconsin, Milwaukee, WI (1985).

Training

• Recertification, Radiation Oncology, American Board of Radiology (2000).
• Board Certification, Radiation Oncology, American Board of Radiology (1990).
• Residency Radiation Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI (1989-1990).
• Residency Radiation Oncology, Presbyterian Hospital, New York, NY (1986-1988).
• Internship Children's Mercy Hospital, Kansas City, MO (1985-1986).

Representative Publications (last 5 years)

• Hatford AC, Paliska MG, Eichler T, Beyer DC, Devineni V, Ibbott G, Kavanagh B, Kent J, Rosenthal S, Schultz CJ, Tripuraneni P, Gaspar L.  American Society of Therapeutic Radiation Oncologists (ASTRO) and American College of Radiology (ACR) practice guidelines for intensity modulated radiation therapy (IMRT).  Int J Rad Onc Bio Phys 73(1):9-14, 2009. 
• Vogelbaum M, Mehta M, Peereboom D, Blumenthal D, Suh J, Jenkins R, Berkey B, Brown P, Schultz C.  Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligdendrogliomas and mixed anaplastic oligoastrocytomas RTOG BR0131.  Neuro-Oncology 11(2):167-175, 2009. 
• Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R, Ang K.  The Final Report of RTOG 9610 A Multi-Institutional Trial of Re-Irradiation Recurrent and Chemotherapy for Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck. Head and Neck Journal  30:3 281-288, 2008.
• Vernon MR. Maheshwari M. Schultz CJ. Michel MA. Wong SJ. Campbell BH. Massey BL. Wilson JF. Wang D.  Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J  Rad Onc Bio & Phys. 70(3):678-84, 2008.
• Yang Q, Feng Y, Qi X, Schultz C, Li XA, Wu H, Wang D.  Synergistic Effect of 15 Lipoxygenase 2 and Radiation on Carcinoma Cells of Head and Neck Cancer Gene Therapy 15:5, 329-330, 2008.
• Chen GP, Ahunbay E, Schultz C, Li XA.  Development of an inverse optimization package to plan non-uniform dose distributions based on spatially inhomoenous radiosensitivity extracted from biological images Medical Physics 34(4), 2007.
• Li XA. Qi XS. Pitterle M. Kalakota K. Mueller K. Erickson BA. Wang D. Schultz CJ. Firat SY. Wilson JF. Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. Int J Rad Onc Bio & Phys 68(2):581-91, 2007.
• Qi XS, Schultz CJ, Li XA.  Possible fractionated regimens for image-guided intensity modulated radiation therapy of large arteriovenous malformations. Physics in Medicine and Biology 52: 5667-5682, 2007.
• Robins HI, Won M, Seiferheld W, Schultz C, Choucair AK, Brachman DG, Demas WF. A phase II trial of conventional radiation therapy plus high dose tamoxifen for the treatment of supratentorial glioblastoma multiforme: RTOG protocol BR-0021. Neuro-Oncology 8(1):47-52 Jan 2006.
• Cardinale R, Won M,  Choucair A, Gillin M, Chakravarti A, Schultz C, Souhami L, Chen A, Pham H,  Mehta M.  A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boost for Supratentorial Glioblastoma Multiforme RTOG 0023. Int J Rad Onc Biol Phys 65:5 1422-1428, 2006.
• Gabayan A, Green S, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter S, Patel A, P Amin P, Tonnesen G, Lustig L, Bastin B, Watson G, Burri S, Stea B.  GliaSite^® brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional study: Neurosurgery 58:4, 701-709, 2006.
• Wang D, Schultz C, Jursinic P, Bialkowski M, Zhu XR,  Brown WD, Rand S,  Michel M, Campbell B, Wong S, Li XA , Wilson JF.   Initial experience of FED/PET/CT guided IMRT of head and neck carcinoma, Int J Rad Onc Biol & Phys 65:1, 143-151, 2006.
• Abrey L, Ben-Porat L, Panageas K, Yahalom J, Berkey B,  Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis l.  The Memorial Sloan-Kettering Cancer Center Prognostic Model for Primary Central Nervous System Lymphoma. J Clin Onc 24:36, 5711-5715, 2006.
• Colman H, Berkey B, Maor M, Groves M,  Schultz C, Vermeulen S, Nelson D, Mehta M,  Yung WK.  Phase II RTOG Trial of Conventional Radiation Therapy Followed by Treatment with Recombinant Interferon-B for Supratentorial Glioblastoma: Results of RTOG 9710. Int J Rad Onc Biol & Phs 66:3, 818-824, 2006.
• Qi XS, Schultz C, Li XA.  An estimation of radiobiologic parameters from Clinical outcomes for radiation treatment planning of brain tumor. Int J Rad Onc Bio Phy 64:5, 1570-1580, 2006.
• Fisher B, Seiferheld W, Schultz C, DeAngelis L, Nelson D, Schold SC, Curran W, Mehta M.  Secondary analysis of Radiation Therapy Oncology Group (RTOG) 93-10 An intergroup phase II combined modality treatment of primary central nervous system lymphoma. Journal of Neuro-oncology 74(2) 201-205, 2005.
• Jursinic P, Rickert K, Gennarelli T, Schultz C.  Effect of Image Uncertainty on the Dosimetry of Trigeminal Neuralgia Irradiation:  Int J Rad Onco Biol Phys 62:5,1559-1567, 2005.